Late-onset neutropenia following rituximab results from a hematopoietic lineage competition due to an excessive BAFF-induced B-cell recovery.

Haematologica

Volumn 92, Issue 2, 2007, Pages

  Terrier, Benjamin ^a   Ittah, Marc ^a   Tourneur, Léa ^a   Louache, Fawzia ^a   Soumelis, Vassili ^a   Lavie, Frédéric ^a   Casadevall, Nicole ^a   Candon, Sophie ^a   Hummel, Aurélie ^a   Mariette, Xavier ^a   Buzyn, Agnès ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

B CELL ACTIVATING FACTOR; CYCLOPHOSPHAMIDE; CYTOKINE; DRUG DERIVATIVE; FLUDARABINE; IMMUNOLOGIC FACTOR; MONOCLONAL ANTIBODY; RITUXIMAB; TNFSF13B PROTEIN, HUMAN; UNCLASSIFIED DRUG; VIDARABINE;

ARTICLE; B LYMPHOCYTE; BLOOD; BONE MARROW; CASE REPORT; CELL CULTURE; CELL LINEAGE; CHEMICALLY INDUCED DISORDER; DRUG COMBINATION; DRUG EFFECT; FEMALE; HUMAN; LYMPHOPOIESIS; MIDDLE AGED; MYELOPOIESIS; NEUTROPENIA; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TIME; WALDENSTROEM MACROGLOBULINEMIA;

ANTIBODIES, MONOCLONAL; B-CELL ACTIVATING FACTOR; B-LYMPHOCYTES; BONE MARROW; CELL LINEAGE; CELLS, CULTURED; CYCLOPHOSPHAMIDE; CYTOKINES; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; LYMPHOPOIESIS; MIDDLE AGED; MYELOPOIESIS; NEUTROPENIA; TIME FACTORS; VIDARABINE; WALDENSTROM MACROGLOBULINEMIA;

EID: 36249025353     PISSN: None     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.11031     Document Type: Article

References (0)